Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sybil M Genther Williams

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Research|July 10, 2007
Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesisJohn P Maufort, Sybil M Genther Williams, Henry C Pitot, et al.
Cancer Research|August 3, 2005
Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogeneSybil M Genther Williams, Gary L Disbrow, Richard Schlegel, et al.
Cancer Cell International|February 17, 2015
Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS statusSybil M Genther Williams, Apryle M Kuznicki, Paula Andrade, et al.
Cancer Cell|December 13, 2006
A negative feedback signaling network underlies oncogene-induced senescenceStéphanie Courtois-Cox, Sybil M Genther Williams, Elizabeth E Reczek, et al.
Current Biology : CB|January 1, 2008
TORC1 is essential for NF1-associated malignanciesCory M Johannessen, Bryan W Johnson, Sybil M Genther Williams, et al.
Frontiers in Immunology|October 29, 2020
Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell ActivationJin-Hwan Han, Mingmei Cai, Jeffery Grein, et al.
Frontiers in Immunology|December 17, 2020
Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With Fc<i>γ</i>R Engagement and Myeloid Cell ActivationJin-Hwan Han, Mingmei Cai, Jeffery Grein, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Research|July 10, 2007
Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesisJohn P Maufort, Sybil M Genther Williams, Henry C Pitot, et al.
Cancer Research|August 3, 2005
Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogeneSybil M Genther Williams, Gary L Disbrow, Richard Schlegel, et al.
Cancer Cell International|February 17, 2015
Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS statusSybil M Genther Williams, Apryle M Kuznicki, Paula Andrade, et al.
Cancer Cell|December 13, 2006
A negative feedback signaling network underlies oncogene-induced senescenceStéphanie Courtois-Cox, Sybil M Genther Williams, Elizabeth E Reczek, et al.
Current Biology : CB|January 1, 2008
TORC1 is essential for NF1-associated malignanciesCory M Johannessen, Bryan W Johnson, Sybil M Genther Williams, et al.
Frontiers in Immunology|October 29, 2020
Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell ActivationJin-Hwan Han, Mingmei Cai, Jeffery Grein, et al.
Frontiers in Immunology|December 17, 2020
Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With Fc<i>γ</i>R Engagement and Myeloid Cell ActivationJin-Hwan Han, Mingmei Cai, Jeffery Grein, et al.
Pageof 1